EVE was founded in London in February 2024 by Dr. Vanessa Awong Eya’a and Emily Westwood. Supported by a team of world-class doctors and scientists, EVE is guided by a commitment to revolutionising women's health through innovation and expertise.
Co-Founder
Dr. Vanessa is a medical doctor within the UK’s National Health Service (NHS), with extensive experience across various specialities, including general practice, geriatrics, acute care, paediatrics, and emergency medicine. She holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Swansea University and a Diplome des Grandes Ecoles in Finance from EDHEC Business School. Before pursuing a medical career, Dr. Vanessa worked in banking for five years. Her passion lies in improving the quality of care and outcomes for patients, which drives her commitment to the innovation behind EVE.
Co-Founder
Emily is a commercial expert with over a decade of experience in business development for fast-growth, B2B, VC-backed early-stage companies. She has a proven track record of solving significant problems by bringing innovative solutions to market, ensuring rapid revenue generation. Emily previously led partnerships for Y Combinator alumni Verto and ran Barclays’ innovation lab in Oxford. She holds a B.Sc. in Economics from University College London (UCL). Emily's expertise ensures that EVE is positioned to bring its cutting-edge technology to the market efficiently.
Advisor
Dr. Maxine is a medical doctor within the NHS, specialising in Obstetrics and Gynaecology. She holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) from University College London (UCL), and brings valuable clinical insights to EVE’s development process.
Advisor
Nick is a medical device expert and Director of Engineering at Binx Health, a company specialising in rapid Point-Of-Care (POC) diagnostic testing. Previously, he chaired the biomedical engineering division of the Institute of Mechanical Engineers. Nick holds an M.Sc. in Biomedical Engineering from Imperial College London and brings significant expertise in medical device development to EVE.
Advisor
David is a board director at Sonosine, a pioneering med-tech company, and co-founder of Spectroma, a deep-tech diagnostics company. With over 25 years of experience in private equity and venture capital, David offers strategic insight and industry expertise. He holds an M.Sc. in Industrial Engineering from Universidad Politecnica de Madrid, and his experience in diagnostics and med-tech innovation is instrumental in guiding EVE’s growth.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.